Firmagon Injection 120 mg/vial contains degarelix acetate, a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. It works by rapidly reducing testosterone levels in the body, which helps slow or stop the growth of prostate cancer cells that depend on testosterone for proliferation. This injection provides an effective alternative to traditional hormonal therapies.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Degarelix Acetate 120 mg per vial
• Dosage Form: Powder for injection (subcutaneous use after reconstitution)

Mechanism of Action

Degarelix is a selective GnRH receptor antagonist. It directly blocks GnRH receptors in the pituitary gland, leading to an immediate reduction in luteinizing hormone (LH) and follicle-stimulating hormone (FSH). As a result, testosterone production in the testes is rapidly suppressed without causing an initial testosterone surge (flare), which is commonly seen with GnRH agonists.

Indications

Firmagon Injection is indicated for:

• Treatment of advanced hormone-dependent prostate cancer
• Patients requiring rapid testosterone suppression
• Cases where prevention of testosterone flare is important

Dosage and Administration

• Administered as a subcutaneous injection by a healthcare professional
• Initial dose is typically 240 mg (given as two 120 mg injections), followed by monthly maintenance doses
• The injection is usually given in the abdominal area
• Proper reconstitution and administration techniques must be followed

Benefits

• Rapid reduction of testosterone levels
• No initial hormone surge (flare-free therapy)
• Effective control of prostate cancer progression
• Convenient once-monthly maintenance dosing

Possible Side Effects

Common side effects may include:

• Injection site reactions (pain, redness, swelling)
• Hot flashes
• Weight gain
• Fatigue
• Increased liver enzymes

Serious side effects may include:

• Cardiovascular issues (heart rhythm changes)
• Severe allergic reactions
• Liver dysfunction
• Electrolyte imbalance

Precautions and Warnings

• Use with caution in patients with cardiovascular disease
• Monitor liver function and electrolyte levels regularly
• May affect blood sugar levels; caution in diabetic patients
• Not indicated for use in women or children
• Regular monitoring of prostate-specific antigen (PSA) and testosterone levels is recommended

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store in a refrigerator (2°C–8°C)
• Do not freeze
• Keep in original packaging to protect from light
• Keep out of reach of children

Conclusion

Firmagon Injection 120 mg/vial is an effective and fast-acting hormonal therapy for advanced prostate cancer. Its ability to suppress testosterone without causing an initial surge makes it a preferred option in many clinical situations. Proper administration and monitoring ensure optimal therapeutic outcomes.